Fausto Roila


Ontology type: schema:Person     


Person Info

NAME

Fausto

SURNAME

Roila

Publications in SciGraph latest 50 shown

  • 2019-03 Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) in SUPPORTIVE CARE IN CANCER
  • 2018 State of the Art of Antiemetic Therapy in SIDE EFFECTS OF MEDICAL CANCER THERAPY
  • 2017-01 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2017-01 Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2017-01 MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update in SUPPORTIVE CARE IN CANCER
  • 2017-01 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting in SUPPORTIVE CARE IN CANCER
  • 2017-01 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2015-01 NICSO: Network Italiano Cure di Supporto in Oncologia – Italian Network for Supportive Care in Oncology in SUPPORTIVE CARE IN CANCER
  • 2013 State of the Art of Antiemetic Therapy in SIDE EFFECTS OF MEDICAL CANCER THERAPY
  • 2011-03 Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009 in SUPPORTIVE CARE IN CANCER
  • 2011-03 Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Guideline update and results of the Perugia consensus conference in SUPPORTIVE CARE IN CANCER
  • 2011-03 Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009 in SUPPORTIVE CARE IN CANCER
  • 2011-03 Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only) in SUPPORTIVE CARE IN CANCER
  • 2011-03 Acute emesis: moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2010 The Burden of Chemotherapy Induced Nausea and Vomiting on Patients’ Daily Lives: Italian Perspectives in HANDBOOK OF DISEASE BURDENS AND QUALITY OF LIFE MEASURES
  • 2010 The Uniscale Assessment of Quality of Life: Applications to Oncology in HANDBOOK OF DISEASE BURDENS AND QUALITY OF LIFE MEASURES
  • 2008-11 Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey in SUPPORTIVE CARE IN CANCER
  • 2007-02 The impact of chemotherapy-induced nausea and vomiting on health-related quality of life in SUPPORTIVE CARE IN CANCER
  • 2007-01 The cost of chemotherapy-induced nausea and vomiting in Italy in SUPPORTIVE CARE IN CANCER
  • 2005-02 Acute emesis: moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2005-02 The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants in SUPPORTIVE CARE IN CANCER
  • 2005-02 Antiemetics in children receiving chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2005-02 Delayed emesis: moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2005-02 Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines in SUPPORTIVE CARE IN CANCER
  • 2005-02 Antiemetics in children receiving chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2004-06 Transferring scientific evidence to oncological practice: a trial on the impact of three different implementation strategies on antiemetic prescriptions in SUPPORTIVE CARE IN CANCER
  • 2003-12 Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2003 Update on Antiemetic Strategies in ACUTE LEUKEMIAS IX
  • 2002-10-01 Do we need new antiemetic guidelines? in SUPPORTIVE CARE IN CANCER
  • 2002-03 Delayed emesis: incidence, pattern, prognostic factors and optimal treatment in SUPPORTIVE CARE IN CANCER
  • 2002 Antiemetic therapies in oncology in PHARMACEUTICAL MEDICINE
  • 2000-03 Prevention of cisplatin-induced delayed emesis: still unsatisfactory in SUPPORTIVE CARE IN CANCER
  • 2000-03 Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO) in QUALITY OF LIFE RESEARCH
  • 1998-04 Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 1998-04 Consensus regarding multiple day and rescue antiemetic therapy in SUPPORTIVE CARE IN CANCER
  • 1998-04 Optimal selection of antiemetics in children receiving cancer chemotherapy in SUPPORTIVE CARE IN CANCER
  • 1998-04 Delayed emesis following anticancer chemotherapy in SUPPORTIVE CARE IN CANCER
  • 1998 Consensus Regarding Multiple-Day and Rescue Antiemetic Therapy in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1998 Consensus Proposal for 5-HT3 Antagonists in the Prevention of Acute Emesis Related to Highly Emetogenic Chemotherapy in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1998 Optimal Selection of Antiemetics in Children Receiving Cancer Chemotherapy in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1998 Delayed Emesis Following Anticancer Chemotherapy in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1997-07 Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions in SUPPORTIVE CARE IN CANCER
  • 1996-07 Methodology of trials with antiemetics in SUPPORTIVE CARE IN CANCER
  • 1996 Methodology of Antiemetic Trials in ANTIEMETICS IN THE SUPPORTIVE CARE OF CANCER PATIENTS
  • 1996 Unsolved Problems and Future Prospects in ANTIEMETICS IN THE SUPPORTIVE CARE OF CANCER PATIENTS
  • 1996 Antiemetic Therapy in Cancer Patients Submitted to Narcotic Analgesics in ANTIEMETICS IN THE SUPPORTIVE CARE OF CANCER PATIENTS
  • 1995-08 Ondansetron Clinical Pharmacokinetics in CLINICAL PHARMACOKINETICS
  • 1994-09 Are there differences among the serotonin antagonists? in SUPPORTIVE CARE IN CANCER
  • 1994-05 Antiemetics in cancer chemotherapy: historical perspective and current state of the art in SUPPORTIVE CARE IN CANCER
  • 1994-03 Cost and Cost-Effectiveness Analysis of Ondansetron Versus Metoclopramide Regimens in PHARMACOECONOMICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.415208.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416377.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417287.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410531.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414818.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7841.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413620.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7548.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419173.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.194645.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7143.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417993.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410566.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9027.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.59062.38", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7605.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416315.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418711.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418019.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Roila", 
        "givenName": "Fausto", 
        "id": "sg:person.01253305517.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253305517.94"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:33", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_311.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01253305517.94'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01253305517.94'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01253305517.94'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01253305517.94'


     

    This table displays all metadata directly associated to this object as RDF triples.

    52 TRIPLES      10 PREDICATES      29 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01253305517.94 schema:affiliation Nb75d966f71a14b4da6ef6f9821d0a0a6
    2 https://www.grid.ac/institutes/grid.194645.b
    3 https://www.grid.ac/institutes/grid.410531.2
    4 https://www.grid.ac/institutes/grid.410566.0
    5 https://www.grid.ac/institutes/grid.413620.2
    6 https://www.grid.ac/institutes/grid.414818.0
    7 https://www.grid.ac/institutes/grid.416315.4
    8 https://www.grid.ac/institutes/grid.416377.0
    9 https://www.grid.ac/institutes/grid.417287.f
    10 https://www.grid.ac/institutes/grid.417993.1
    11 https://www.grid.ac/institutes/grid.418019.5
    12 https://www.grid.ac/institutes/grid.418711.a
    13 https://www.grid.ac/institutes/grid.419173.9
    14 https://www.grid.ac/institutes/grid.59062.38
    15 https://www.grid.ac/institutes/grid.7143.1
    16 https://www.grid.ac/institutes/grid.7548.e
    17 https://www.grid.ac/institutes/grid.7605.4
    18 https://www.grid.ac/institutes/grid.7841.a
    19 https://www.grid.ac/institutes/grid.9027.c
    20 schema:familyName Roila
    21 schema:givenName Fausto
    22 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253305517.94
    23 schema:sdDatePublished 2019-03-07T14:33
    24 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    25 schema:sdPublisher N445d6c9ab70544cf87149b71661d654e
    26 sgo:license sg:explorer/license/
    27 sgo:sdDataset persons
    28 rdf:type schema:Person
    29 N445d6c9ab70544cf87149b71661d654e schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 Nb75d966f71a14b4da6ef6f9821d0a0a6 schema:affiliation https://www.grid.ac/institutes/grid.415208.a
    32 sgo:isCurrent true
    33 rdf:type schema:OrganizationRole
    34 https://www.grid.ac/institutes/grid.194645.b schema:Organization
    35 https://www.grid.ac/institutes/grid.410531.2 schema:Organization
    36 https://www.grid.ac/institutes/grid.410566.0 schema:Organization
    37 https://www.grid.ac/institutes/grid.413620.2 schema:Organization
    38 https://www.grid.ac/institutes/grid.414818.0 schema:Organization
    39 https://www.grid.ac/institutes/grid.415208.a schema:Organization
    40 https://www.grid.ac/institutes/grid.416315.4 schema:Organization
    41 https://www.grid.ac/institutes/grid.416377.0 schema:Organization
    42 https://www.grid.ac/institutes/grid.417287.f schema:Organization
    43 https://www.grid.ac/institutes/grid.417993.1 schema:Organization
    44 https://www.grid.ac/institutes/grid.418019.5 schema:Organization
    45 https://www.grid.ac/institutes/grid.418711.a schema:Organization
    46 https://www.grid.ac/institutes/grid.419173.9 schema:Organization
    47 https://www.grid.ac/institutes/grid.59062.38 schema:Organization
    48 https://www.grid.ac/institutes/grid.7143.1 schema:Organization
    49 https://www.grid.ac/institutes/grid.7548.e schema:Organization
    50 https://www.grid.ac/institutes/grid.7605.4 schema:Organization
    51 https://www.grid.ac/institutes/grid.7841.a schema:Organization
    52 https://www.grid.ac/institutes/grid.9027.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...